Haku
Viitteet 1-2 / 2
Interchangeability of Biosimilars : A European Perspective
(Springer International Publishing, 2017-04-01)
Many of the best-selling ‘blockbuster’ biological medicinal products are, or will soon be, facing competition from similar biological medicinal products (biosimilars) in the EU. Biosimilarity is based on the comparability ...
Roundtable on biosimilars with European regulators and medical societies, Brussels, Belgium, 12 January 2016
(Pro Pharma Communications International, 2016)